Testicular cancer before and after cisplatin: a 30-year view

被引：0
作者：
Ansell, Wendy [1 ]
Shamash, Jonathan [1 ]
机构：
[1] St Bartholomews Hosp, London EC1A 7BE, England
来源：
INTERNATIONAL JOURNAL OF UROLOGICAL NURSING | 2008年 / 2卷 / 03期
关键词：
Historical perspective; Multidisciplinary working; Survivorship; Testicular cancer; Testicular germ cell tumours; Treatment advances;
D O I：
10.1111/j.1749-771X.2008.00060.x
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
Exciting changes have been made in the management of testicular germ cell cancers over the past 30 years. Today, more than 80% of men who present with metastatic disease are cured compared with about 15% in the early 1970s. This means that there are a large number of survivors and many of them have willingly provided information that can be used in shaping the management of other malignancies. The paper aims to summarize the current management of testicular germ cell cancers comparing the situation in the pre-platinum era with that today and to consider current and future developments in the management of this disease.
引用
收藏
页码：103 / 112
页数：10
相关论文
共 50 条
  • [41] The limited efficacy of methotrexate, actinomycin D and cisplatin (MAP) for patients with advanced testicular cancer
    Miyazaki, J
    Kawai, K
    Hayashi, H
    Onozawa, M
    Tsukamoto, S
    Miyanaga, N
    Hinotsu, S
    Shimazui, T
    Akaza, H
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2003, 33 (08) : 391 - 395
  • [42] Fertility after chemotherapy for testicular germ cell cancer
    Pont, J
    Albrecht, W
    FERTILITY AND STERILITY, 1997, 68 (01) : 1 - 5
  • [43] Semen cryopreservation after orchidectomy in men with testicular cancer
    Sibert, L
    Rives, N
    Rey, D
    Mace, B
    Grise, P
    BJU INTERNATIONAL, 1999, 84 (09) : 1038 - 1042
  • [44] Testosterone Level in Testicular Cancer Patients after Chemotherapy
    Sarfraz, M.
    Ashraf, Y.
    Sajid, S.
    Ashraf, M. A.
    WEST INDIAN MEDICAL JOURNAL, 2015, 64 (05) : 487 - 494
  • [45] Orchidectomy after Primary Chemotherapy for Metastatic Testicular Cancer
    Ramsey, S.
    Kerr, G.
    Howard, G. C. W.
    Donat, R.
    UROLOGIA INTERNATIONALIS, 2013, 91 (04) : 439 - 444
  • [46] Endocrinological late effects after chemotherapy for testicular cancer
    Berger, CC
    Bokemeyer, C
    Schuppert, F
    Schmoll, HJ
    BRITISH JOURNAL OF CANCER, 1996, 73 (09) : 1108 - 1114
  • [47] Testicular cancer: Our experience after 10 years
    Valsero Herguedas, Maria Esther
    Pascual Samaniego, Miguel
    Garcia Lagarto, Elena
    Martin Martin, Sergio
    Fe Munoz Moreno, Maria
    Cortinas Gonzalez, Jose Ramon
    ARCHIVOS ESPANOLES DE UROLOGIA, 2012, 65 (04): : 467 - 475
  • [48] Increased aneuploidy in spermatozoa from testicular tumour patients after chemotherapy with cisplatin, etoposide and bleomycin
    De Mas, P
    Daudin, M
    Vincent, MC
    Bourrouillou, G
    Calvas, P
    Mieusset, R
    Bujan, L
    HUMAN REPRODUCTION, 2001, 16 (06) : 1204 - 1208
  • [49] Thromboembolic events after high-intensity training during cisplatin-based chemotherapy for testicular cancer: Case reports and review of the literature
    Thorsen, Lene
    Haugnes, Hege S.
    Fossa, Sophie D.
    Brydoy, Marianne
    Tandstad, Torgrim
    Wisloff, Torbjorn
    Gjerset, Gunhild M.
    Edvardsen, Elisabeth
    Larsen, Karl-Otto
    Sandset, Per Morten
    Henriksson, Carola E.
    Raastad, Truls
    Negaard, Helene F. S.
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (11) : 3189 - 3198
  • [50] CLINICAL AND BIOCHEMICAL LONG-TERM TOXICITY AFTER POSTOPERATIVE CISPLATIN-BASED CHEMOTHERAPY IN PATIENTS WITH LOW-STAGE TESTICULAR CANCER
    FOSSA, SD
    LEHNE, G
    HEIMDAL, K
    THEODORSEN, L
    ONCOLOGY, 1995, 52 (04) : 300 - 305
12345